Table of Contents Toggle A Lifelong Condition, Not A Willpower Problem For many people, obesity begins early and persists despite repeated attempts to control it
Aids in regulating blood sugar and reducing cravings
If you are interested in taking Byetta, talk to your healthcare provider
Peptides referenced below are research compounds and, in some cases, the active ingredients in FDA-approved finished pharmaceutical products
Durability of Results: Maintenance Studies: Tirzepatide (SURMOUNT-3): Continued treatment: Additional 5.5% weight loss Stopped treatment: Regained 14% of weight Conclusion: Need ongoing treatment Semaglutide (STEP-4): Continued treatment: Maintained loss, continued losing Stopped treatment: Regained most weight Conclusion: Need ongoing treatment Phentermine: FDA-approved for 12 weeks only Weight regain after stopping is universal Not a long-term solution All Weight Loss Medications: Obesity is chronic disease Medications treat symptoms, dont cure Stopping medication weight regain Long-term or indefinite use necessary for sustained results Safety Profile Comparison: Discontinuation Due to Side Effects: Tirzepatide: 6.2% Semaglutide: 6.9% Liraglutide: 9.9% Naltrexone-bupropion: 25% (very high) Orlistat: 15-20% Phentermine-topiramate: 8-10% GLP-1s have excellent tolerability considering their effectiveness
[DOI] [PubMed] [Google Scholar] 43.Lin MT, Beal MF
